The largest database of trusted experimental protocols

Hygromycin b

Manufactured by Wisent
Sourced in Germany

Hygromycin B is a laboratory product used as a selection marker in genetic engineering experiments. It is an antibiotic that inhibits protein synthesis in eukaryotic cells, allowing for the identification of cells that have successfully incorporated a desired genetic construct.

Automatically generated - may contain errors

4 protocols using hygromycin b

1

Stable Cell Line Development via Inducible Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stable cell line populations were created by transfecting HEK293 T-REx cells with the pcDNA5-FlagBirA*-FRT/TO constructs and the accessory plasmid pOG44 (Invitrogen, V600520) according to manufacturer’s instructions. Selection was performed using hygromycin B (Wisent, 450-141-XL) at a concentration of 200 μg/ml. For induction of the gene of interest, tetracycline was used at concentration of 1 μg/ml, and media was supplemented with biotin (50 μM; Bio Basic, BB0078). Biotinylation was generally performed for 20 h.
+ Open protocol
+ Expand
2

Tetracycline-Inducible U2OS Cell Line for CSNK2A1 Kinase Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human osteosarcoma U2OS cells expressing the tetracycline responsible element of Flp-In™ T-REx system (FT-U2OS, gift from Karmella Haynes, Arizona State University, (Haynes and Silver, 2011 (link))) were cultured in Dulbecco’s Modified Eagle’s medium without sodium pyruvate, L-Arg, and L-Lys (DMEM, Wisent) supplemented with 10% of 10 kDa cut-off fetal bovine serum (Wisent), 100 μg/mL streptomycin, 100 units/mL penicillin (Thermo), 15 μg/mL blasticidin (Wisent), and 150 μg/mL hygromycin B (Wisent). The cell media was also supplemented with 0.398 mM L-Arg, 0.274 mM L-Lys, and 3.47 mM L-Pro. The cells were grown at 37°C with 5% CO2 in 10 cm dishes (TPP, FroggaBio) or in 6-well plates (Greiner BioOne). Following the recommendations of Flp-In™ T-REx cell line development of ThermoFisher Scientific (http://www.thermofisher.com/), we developed cell lines stably expressing the wild-type CSNK2A1-HA (WT) or the inhibitor resistant forms of double mutant (DM, V66A/I174A) of the kinase with tight tetracycline regulation. The exogenous CSNK2A1 has a C-terminal HA tag to be able to distinguish from the endogenous kinase. The cell lines were induced 48h prior to inhibitor treatment with 1 μg/mL tetracycline and were kept induced during the inhibitor treatment. Cells were challenged in two independent experiment with a range of inhibitor concentrations as indicated in the figures.
+ Open protocol
+ Expand
3

DHFR Protein-Fragment Complementation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two libraries were employed for the DHFR PCA screen: a library with C-terminal DHFR F[1,2] tag and a library with C-terminal DHFR F[3] tag (Tarassov et al., 2008 (link)). A query strain was taken out from each library with Slt2 tagged with either fragment and mated against the opposite libraries by overnight incubation on YPD. After mating, diploid cells were selected for by incubation for 2 days on YPD medium with 100 μg/ml nourseothricin (Werner Bioagents, Jena, Germany) and 250 μg/ml hygromycin B (Wisent Bioproducts, Saint-Jean-Baptiste, Canada). This step was repeated once. Next, the strains were transferred to synthetic complete medium (4% (w/v) Noble agar) with 200 μg/ml methotrexate (Bioshop Canada, Montréal, Canada) and without adenine or ammonium sulfate. Pictures of the strains were taken after 4 days incubation at 30°C. Colony size was analyzed using the Balony software (Young and Loewen, 2013 (link)).
+ Open protocol
+ Expand
4

Lentiviral shRNA Transduction and Selection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Puromycin resistant pLKO.1 lentiviral shRNA vectors were retrieved from the arrayed Mission TRC genome-wide shRNA collections purchased from Sigma-Aldrich Corporation. Additional information about the shRNA vectors can be found at http://www.sigmaaldrich.com/life-science/functional-genomics-andrnai/shrna/library-information.html or http://www.broad.mit.edu/genome_bio/trc/rnai.html, using the TRCN number. The following lentiviral shRNA vector were used: TRCN0000003810 (hHIF-1α) and TRCN0000027298 (hIDH1). The Non-Target shRNA Control (Sigma: SHC002) was used as negative control. shRNA sequences from TRCN0000041627 (mPHGDH) and TRCN0000324779 (mASNS) were subcloned into pLV[shRNA]-Hygro-U6 (by VectorBuilder), and that from TRCN0000041715 (mIDH1) into a pLKO.1-neo vector (a gift from Sheila Stewart, Addgene 13425), to change antibiotic selection. Lentiviral supernatants were generated as described at http://www.broadinstitute.org/rnai/public/resources/protocols. Supernatants were applied on target cells with polybrene (6 μg/mL). Cells were reinfected the next day and, 2 days later, selected with Puromycin (4μg/mL; Bio Basic), hygromycin B (400μg/ml, Wisent) or G418 (250μg/ml, Bio Basic) for 72 hours.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!